Stock listing

NASDAQ:PROK ProKidney Corp. Stock

Home listing (NASDAQ) of ProKidney Corp.

Follow ProKidney Corp. into a list and get an email when it puts out news.

Share price · NASDAQ:PROK

$1.04 USD 0.00 (0.0%)

Close on Nov 20, 2026

Past year -50.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.02 – $1.08 USDNov 20, 2026
Volume
1.90M sharesNov 20, 2026
Market cap
$217.3M USDAt the close on Nov 20, 2026 · price × 208.9M shares outstanding
52-week range
$0.87 – $2.65 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.22M USDMedian day 1.17M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
ProKidney Corp. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PROK · Home$1.04 USD0.00 (0.0%)1,900,570$1.03$1.08$1.023$1.04Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PROK · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.040.000.0%$1.03$1.08$1.0231,900,570
$1.04-0.06-5.5%$1.09$1.10$1.041,796,932
$1.10+0.06+5.8%$1.06$1.12$1.0351,136,363
$1.04-0.005-0.5%$1.025$1.10$1.011,708,501
$1.045-0.105-9.1%$1.16$1.16$1.021,292,085
$1.15+0.02+1.8%$1.12$1.18$1.081,086,889
$1.13+0.02+1.8%$1.15$1.18$1.11595,566
$1.11-0.04-3.5%$1.12$1.165$1.065733,340
$1.15+0.01+0.9%$1.14$1.27$1.101,466,045
$1.14+0.075+7.0%$1.05$1.16$1.04950,830
$1.065-0.055-4.9%$1.11$1.11$1.001,169,583
$1.12+0.05+4.7%$1.09$1.14$1.011,236,832
$1.07-0.05-4.5%$1.105$1.13$1.001,544,109
$1.12-0.175-13.5%$1.33$1.35$0.877,296,417
$1.295-0.175-11.9%$1.41$1.459$1.291,730,407
$1.47-0.05-3.3%$1.51$1.53$1.43821,228
$1.52+0.005+0.3%$1.47$1.595$1.461,497,812
$1.515+0.155+11.4%$1.39$1.55$1.3551,367,503
$1.36-0.05-3.5%$1.41$1.435$1.35761,674
$1.41-0.02-1.4%$1.43$1.44$1.37535,233
$1.43-0.01-0.7%$1.42$1.48$1.415584,484
$1.440.000.0%$1.44$1.49$1.44601,289
$1.44+0.045+3.2%$1.40$1.51$1.351,489,346
$1.395+0.065+4.9%$1.35$1.41$1.35966,948
$1.33-0.125-8.6%$1.43$1.474$1.3051,669,719
$1.455-0.015-1.0%$1.44$1.485$1.421,109,236
$1.47-0.10-6.4%$1.54$1.57$1.412,125,778
$1.57-0.10-6.0%$1.65$1.68$1.531,598,948
$1.67-0.07-4.0%$1.71$1.74$1.66607,842
$1.74+0.08+4.8%$1.65$1.75$1.6351,385,958
$1.66+0.09+5.7%$1.55$1.67$1.531,133,741
$1.57-0.03-1.9%$1.56$1.60$1.55832,186
$1.60+0.02+1.3%$1.58$1.61$1.555771,314
$1.58-0.14-8.1%$1.69$1.735$1.58985,935
$1.72+0.01+0.6%$1.72$1.745$1.661,089,631
$1.71+0.05+3.0%$1.66$1.76$1.6351,511,176
$1.66+0.03+1.8%$1.65$1.675$1.601,196,615
$1.63+0.02+1.2%$1.61$1.68$1.6051,003,290
$1.61+0.01+0.6%$1.58$1.64$1.541,814,558
$1.60-0.08-4.8%$1.67$1.69$1.5652,166,921
$1.68+0.03+1.8%$1.65$1.689$1.601,726,689
$1.65-0.18-9.8%$1.81$1.84$1.651,440,852
$1.83+0.055+3.1%$1.78$1.86$1.772588,523
$1.775-0.135-7.1%$1.90$1.909$1.7151,772,952
$1.91+0.11+6.1%$1.79$1.98$1.799,450,911
$1.80-0.05-2.7%$1.87$1.905$1.801,048,839
$1.85+0.11+6.3%$1.79$1.86$1.761,813,747
$1.74-0.07-3.9%$1.81$1.828$1.721,203,113
$1.81+0.01+0.6%$1.80$1.845$1.79952,598
$1.80-0.04-2.2%$1.88$1.925$1.801,072,321
$1.84-0.01-0.5%$1.82$1.86$1.752,491,533
$1.85-0.14-7.0%$1.98$1.985$1.831,409,130
$1.99-0.02-1.0%$2.05$2.08$1.97929,611
$2.01+0.09+4.7%$1.90$2.09$1.891,225,328
$1.92+0.01+0.5%$1.92$1.995$1.895751,466
$1.91+0.06+3.2%$1.86$1.95$1.845641,215
$1.85-0.04-2.1%$1.86$1.90$1.825695,726
$1.89+0.06+3.3%$1.83$1.915$1.7811,261,895
$1.83+0.01+0.5%$1.82$1.90$1.7751,128,967
$1.82+0.08+4.6%$1.73$1.835$1.731,157,090
$1.74+0.01+0.6%$1.74$1.75$1.67568,462
$1.73+0.12+7.5%$1.62$1.76$1.615751,688
$1.610.000.0%$1.59$1.63$1.56980,539
$1.61+0.19+13.4%$1.43$1.62$1.431,725,776
$1.42-0.06-4.1%$1.47$1.47$1.381,828,077
Ticker
NASDAQ:PROK
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All ProKidney Corp. news

ProKidney Corp. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
11 in the last 12 months · 77 in all · newest Nov 18, 2026 · oldest 2022
Decks
22 decks · latest Nov 9, 2026

Where ProKidney Corp. is listed

ListingExchangeCountryCurrency
NASDAQ:PROK · Home listing · This pageNASDAQUnited StatesUSD
BMV:PROKBMVMexicoMXN
BOATS:PROKBOATSUnited StatesUSD
BIVA:PROKBIVAMexicoMXN

Cash and shares

Nov 2026 deck · ProKidney — Investor Presentation (November 2026)

Cash
$142 million

The slide these figures come from

Valuation

EV/sales 100× against a median of 1.3×: 5th lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$77.56M USD
P/E
Loss
EV/sales
100×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
Negative equity
Beta vs S&P 500
1.61

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
ProKidney Corp. · NASDAQ:PROKUS$217.3MUS$77.56Mn/a100×n/an/an/an/a1.61
Enanta Pharmaceuticals, Inc. · NASDAQ:ENTAUS$222.2MUS$82.43Mn/a1.3×n/a2.8×−108.3%0.7×1.11
Clover Biopharmaceuticals Ltd. · HKEX:2197US$222.0MUS$206.6Mn/a404×n/an/an/an/an/a
Northwest Biotherapeutics, Inc. · OTC:NWBOUS$220.0MUS$283.8Mn/a99.4×n/an/an/an/a0.90
Keros Therapeutics, Inc. · NASDAQ:KROSUS$219.7M−US$24.67Mn/a−0.6×n/a0.8×−152.7%0.1×1.16
Immuneering Corporation · NASDAQ:IMRXUS$218.7MUS$160.5Mn/an/an/a1.3×n/a0.0×1.17
Allogene Therapeutics, Inc. · NASDAQ:ALLOUS$217.5M−US$7.44Mn/a−1.6×n/a0.6×n/a0.2×1.93
Pyxis Oncology, Inc. · NASDAQ:PYXSUS$216.5MUS$160.9Mn/an/an/a5.2×n/a0.0×0.89
Oryzon Genomics SA · BME:ORYUS$216.4MUS$206.7Mn/an/an/a1.6×n/a0.1×n/a
Rocket Pharmaceuticals, Inc. · NASDAQ:RCKTUS$214.1M−US$25.02Mn/an/an/a0.7×n/a0.1×1.72
Orum Therapeutics, Inc. · KRX:475830US$212.5MUS$24.22M15.4×n/an/a1.5×n/a0.0×n/a
Median of the othersUS$218.1MUS$121.4M15.4×1.3×1.4×−130.5%0.1×1.16

Forecasts

4 strong buy · 1 hold · 1 sell · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
7.88 USD · Analysts' mean
EPS, year to Dec 2026
-0.61 · 4 analysts
Revenue, year to Dec 2026
750K · 2 analysts

Team and board

Officers

OfficerRole
Bruce CulletonChief Executive Officer
James CoulstonChief Financial Officer
Todd C. GirolamoChief Legal Officer and Secretary
Emily ButlerSVP, Biometrics
Jake TreeseSVP, Head of Quality
Joseph StavasSVP, Interventional Procedures
Carla PoulsonChief People Officer
Darin J. WeberChief Regulatory Officer
Farah AliChief Medical Officer
Greg MadisonChief Commercial Officer
Ken LockeChief Technical Officer
Richard WilliamsChief Information Officer

Board

DirectorRole
Pablo LegorretaChairman of the Board
Alan M. LotvinBoard Member
Brian J. G. PereiraDirector
Bruce CulletonChief Executive Officer
Jennifer FoxBoard Member
Uma SinhaBoard Member
William F. DoyleLead Independent Director

Events

QuarterResultsShare move
Q3 2026Nov 12, 2026 · After close−9.1%
Q2 2026Aug 10, 2026 · After close−4.7%
Q1 2026May 15, 2026−5.8%
Q4 2025Mar 18, 2026 · After close−6.3%
Q3 2025Nov 10, 2025 · After close+3.7%
Q2 2025Aug 12, 2025 · After close+5.8%
Q1 2025May 12, 2025+20.4%
Q4 2024Mar 17, 2025 · Before open+5.7%
Q3 2024Nov 12, 2024 · Before open−4.7%
Q2 2024Aug 9, 2024 · Before open+4.3%
All 20 quarters
QuarterResultsShare move
Q1 2024May 10, 2024 · After close+9.6%
Q4 2023Mar 22, 2024 · Before open+2.2%
Q3 2023Nov 14, 2023 · After close−8.6%
Q2 2023Aug 10, 2023 · After close+1.7%
Q1 2023May 11, 2023 · After close+1.0%
Q4 2022Mar 28, 2023 · After close−2.6%
Q3 2022Nov 14, 2022 · Before open−1.6%
Q2 2022Aug 12, 2022 · After close−2.5%
Q1 2022May 16, 2022 · After close+0.1%
Q4 2021Mar 24, 2022 · After close0.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck40 slidesNov 9, 2026
Corporate Update (October 2026)Corporate update55 slidesOct 27, 2026
Investor Presentation (August 2026)Investor deck33 slidesAugust 2026
Investor Presentation (May 2026)Investor deck33 slidesMay 15, 2026
Investor Presentation (February 2026)Investor deck34 slidesFeb 2, 2026
Investor Presentation (January 2026)Investor deck34 slidesJan 12, 2026
Investor Presentation (July 2025)Investor deck19 slidesJul 15, 2025
Investor Presentation (July 2025)Investor deck18 slidesJul 8, 2025
J.P. Morgan Healthcare Conference 2025Conference23 slidesJanuary 2025
Investor Presentation (September 2024)Investor deck24 slidesSep 3, 2024
All 22 decks
DeckKindSlidesDate
Technical Presentation (June 2024)Technical16 slidesJun 14, 2024
Corporate Update (June 2024)Corporate update27 slidesJun 10, 2024
Technical Presentation (May 2024)Technical10 slidesMay 29, 2024
Investor Presentation (January 2024)Investor deck31 slidesJan 26, 2024
Technical Presentation (November 2023)Technical29 slidesNov 13, 2023
Investor Presentation (September 2023)Investor deck29 slidesSep 11, 2023
Investor Presentation (March 2023)Investor deck27 slidesMar 6, 2023
J.P. Morgan Investor Conference January 2023Conference28 slidesJan 10, 2023
Investor Presentation (September 2022)Investor deck37 slidesSep 8, 2022
Social Capital Suvretta Holdings Corp. III — SPAC Merger (April 2022)SPAC merger56 slidesApr 28, 2022
Social Capital Suvretta Holdings Corp. III — SPAC Merger (January 2022)SPAC merger19 slidesJan 18, 2022
Social Capital Suvretta Holdings Corp. III — SPAC Merger (January 2022)SPAC merger70 slidesJan 18, 2022

Open Decks

IPO

Went public as Social Capital Suvretta Holdings Corp. III, a blank check company (SPAC). Priced at US$10.00 a share on Jun 29, 2021.

Price
US$10.00 a share
Shares offered
22,000,000 Class A ordinary shares
Offering size
US$220 million
Underwriters' option
Up to 3,300,000 more shares
Underwriters
Morgan Stanley, SoFi · In the order on the cover
Shares delivered
On or about Jul 2, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceApr 21, 2021
Filed publiclyJun 2, 2021
Amended twiceNewest Jun 25, 2021
Shares registered with an exchangeJun 29, 2021
Declared effective by the SECJun 29, 2021
Final prospectus, with the priceJul 1, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Jul 1, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue893.0K76.0K0000
Cost of revenue5.72M3.17M3.04M1.98M
Gross profit893.0K76.0K-3.17M-3.04M-1.98M
Research and development114.1M127.7M106.7M82.1M46.3M21.0M75.2M
Selling, general and administrative51.8M56.1M44.8M70.9M8.86M5.67M4.16M
Operating income-165.0M-183.7M-151.5M-153.0M-55.1M-27.0M-79.4M
Depreciation and amortization6.58M5.43M3.85M3.04M1.98M964.0K867.0K
EBITDA-158.4M-178.2M-147.7M-150.0M-53.1M-26.1M-78.5M
Interest expense4.00K9.00K12.0K215.0K000
Income before tax-151.2M-163.9M-129.5M-147.2M-55.1M-27.0M-79.3M
Income tax414.0K-598.0K6.00M896.0K38.0K-232.0K361.0K
Net income-69.0M-61.2M-35.5M-148.1M-55.1M-26.7M-79.6M
Earnings per share, basic-0.52-0.62-0.57-0.23-1.73-0.14-1.01
Earnings per share, diluted-0.23

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents108.5M99.1M60.6M490.3M20.6M4.58M15.2M
Short-term investments161.5M259.2M302.3M0
Receivables1.13M2.45M1.38M
Current assets280.7M395.9M374.1M504.7M27.3M5.58M15.4M
Property, plant and equipment51.2M42.2M42.1M10.7M11.4M10.5M3.33M
Goodwill427.6K641.4K
Total assets335.6M441.1M420.6M518.0M40.3M16.7M19.6M
Accounts payable940.0K3.63M5.10M3.04M2.83M781.0K480.0K
Current liabilities30.7M36.2M25.0M10.9M12.3M5.50M2.71M
Total debt4.04M3.24M4.41M2.40M1.33M1.56M1.11M
Total liabilities34.8M39.4M29.2M13.1M13.4M6.84M3.72M
Shareholders' equity-1.01B-995.0M-1.10B-1.10B26.9M9.86M15.9M
Shares outstanding133.9M97.9M61.7M61.5M31.9M186.5M78.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-120.1M-126.4M-90.1M-77.1M-50.3M-25.2M-76.8K
Capital spending-15.2M-29.5M-34.2M-1.85M-5.19M-5.46M-1.30K
Free cash flow-135.3M-155.9M-124.3M-78.9M-55.5M-30.6M-78.1K
Cash from investing104.0M20.4M-330.0M-1.74M-5.19M-5.46M-2.97K
Cash from financing25.6M144.4M-9.55M548.5M71.5M20.0M20.0K
Share buybacks00-9.50M00
Change in cash9.42M38.5M-429.6M469.7M16.0M-10.6M15.2K

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 12, 2026ResultsSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
424B5 · ProspectusNov 12, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 12, 2026Other filingsSEC
8-K · Current reportNov 9, 2026ResultsSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
4 · Change in ownershipOct 30, 2026Insider tradeSEC
8-K · Current reportOct 29, 2026Material contractSEC
S-3 · Registration statementOct 29, 2026Offer documentSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleAug 18, 2026Other filingsSEC
144 · Notice of proposed saleAug 18, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2026Big-stake noticeSEC
8-K · Current reportAug 10, 2026ResultsSEC
10-Q · Quarterly reportAug 10, 2026Quarterly reportSEC
4 · Change in ownershipAug 6, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
8-K · Current reportMay 29, 2026Meeting outcomeSEC
8-K · Current reportMay 15, 2026ResultsSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 30, 2026Big-stake noticeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
ARS · Annual report to shareholdersApr 17, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 17, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 17, 2026Meeting noticeSEC
S-8 · Registration statement for employee plansMar 18, 2026Offer documentSEC
8-K · Current reportMar 18, 2026ResultsSEC
10-K · Annual reportMar 18, 2026Annual reportSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeFeb 12, 2026Big-stake noticeSEC
8-K · Current reportFeb 2, 2026Current reportSEC
8-K · Current reportJan 12, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveNov 19, 2025Other filingsSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
8-K · Current reportNov 10, 2025ResultsSEC
10-Q · Quarterly reportNov 10, 2025Quarterly reportSEC
DEL AMNov 4, 2025Other filingsSEC
POS AM · Amendment to an effective registrationOct 21, 2025Offer documentSEC
8-K · Current reportOct 17, 2025Material contractSEC
8-K · Current reportAug 12, 2025ResultsSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 7, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 17, 2025Big-stake noticeSEC
8-K12B/AJul 16, 2025Other filingsSEC
8-K · Current reportJul 15, 2025Current reportSEC
8-K · Current reportJul 14, 2025Material contractSEC
424B5 · ProspectusJul 14, 2025Offer documentSEC
4 · Change in ownershipJul 11, 2025Insider tradeSEC
4 · Change in ownershipJul 9, 2025Insider tradeSEC
144 · Notice of proposed saleJul 8, 2025Other filingsSEC
8-K · Current reportJul 8, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveJul 8, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveJul 8, 2025Other filingsSEC
POS AM · Amendment to an effective registrationJul 3, 2025Offer documentSEC
S-8 POSJul 3, 2025Offer documentSEC
S-8 POSJul 3, 2025Offer documentSEC
S-8 POSJul 3, 2025Offer documentSEC
S-8 POSJul 3, 2025Offer documentSEC
POS AM · Amendment to an effective registrationJul 3, 2025Offer documentSEC
8-K12BJul 3, 2025Other filingsSEC
8-K · Current reportJul 1, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 5, 2025Big-stake noticeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
8-K · Current reportMay 30, 2025Meeting outcomeSEC
8-K · Current reportMay 12, 2025ResultsSEC
10-Q · Quarterly reportMay 12, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 6, 2025Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveApr 29, 2025Other filingsSEC
ARS · Annual report to shareholdersApr 28, 2025Annual reportSEC
424B3 · ProspectusApr 28, 2025Offer documentSEC
CORRESP · Letter to the SECApr 24, 2025Other filingsSEC
4 · Change in ownershipApr 24, 2025Insider tradeSEC
4 · Change in ownershipApr 21, 2025Insider tradeSEC
4 · Change in ownershipApr 18, 2025Insider tradeSEC
4 · Change in ownershipApr 16, 2025Insider tradeSEC
4 · Change in ownershipApr 14, 2025Insider tradeSEC
UPLOAD · Letter from the SECApr 4, 2025Other filingsSEC
S-4 · Registration statementMar 31, 2025Offer documentSEC
S-8 · Registration statement for employee plansMar 20, 2025Offer documentSEC
10-K · Annual reportMar 17, 2025Annual reportSEC
8-K · Current reportMar 17, 2025ResultsSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipFeb 6, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 6, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 6, 2025Insider tradeSEC
8-K · Current reportJan 21, 2025Material contractSEC
8-K · Current reportNov 22, 2024Material contractSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
8-K · Current reportNov 12, 2024ResultsSEC
SC 13G · Big-stake noticeNov 8, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedOct 22, 2024Big-stake noticeSEC
3 · Initial statement of ownershipOct 22, 2024Insider tradeSEC
SC 13G · Big-stake noticeOct 18, 2024Big-stake noticeSEC
4 · Change in ownershipSep 20, 2024Insider tradeSEC
144 · Notice of proposed saleSep 19, 2024Other filingsSEC
4 · Change in ownershipSep 16, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
8-K · Current reportSep 3, 2024Current reportSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
8-K · Current reportAug 9, 2024ResultsSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC
4 · Change in ownershipJul 29, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJun 25, 2024Big-stake noticeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
4 · Change in ownershipJun 20, 2024Insider tradeSEC
4 · Change in ownershipJun 14, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJun 14, 2024Big-stake noticeSEC
8-K · Current reportJun 13, 2024Material contractSEC
424B5 · ProspectusJun 13, 2024Offer documentSEC
424B5 · ProspectusJun 10, 2024Offer documentSEC
8-K · Current reportJun 10, 2024Current reportSEC
4 · Change in ownershipJun 3, 2024Insider tradeSEC
4 · Change in ownershipJun 3, 2024Insider tradeSEC
4 · Change in ownershipJun 3, 2024Insider tradeSEC
4 · Change in ownershipJun 3, 2024Insider tradeSEC
4 · Change in ownershipJun 3, 2024Insider tradeSEC
4 · Change in ownershipJun 3, 2024Insider tradeSEC
4 · Change in ownershipJun 3, 2024Insider tradeSEC
8-K · Current reportMay 31, 2024Meeting outcomeSEC
8-K · Current reportMay 29, 2024Current reportSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
144 · Notice of proposed saleMay 20, 2024Other filingsSEC
4 · Change in ownershipMay 16, 2024Insider tradeSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
8-K · Current reportMay 10, 2024ResultsSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
4 · Change in ownershipApr 23, 2024Insider tradeSEC
144 · Notice of proposed saleApr 18, 2024Other filingsSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
4 · Change in ownershipApr 16, 2024Insider tradeSEC
144 · Notice of proposed saleApr 16, 2024Other filingsSEC
144 · Notice of proposed saleApr 12, 2024Other filingsSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
3 · Initial statement of ownershipApr 2, 2024Insider tradeSEC
144 · Notice of proposed saleApr 1, 2024Other filingsSEC
8-K · Current reportMar 25, 2024Management or board changeSEC
S-8 · Registration statement for employee plansMar 22, 2024Offer documentSEC
8-K · Current reportMar 21, 2024ResultsSEC
10-K · Annual reportMar 21, 2024Annual reportSEC
8-K/A · Current report, amendedMar 18, 2024Management or board changeSEC
8-K/A · Current report, amendedMar 18, 2024Management or board changeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
8-K · Current reportFeb 12, 2024Management or board changeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2024Big-stake noticeSEC
4 · Change in ownershipFeb 6, 2024Insider tradeSEC
4 · Change in ownershipFeb 6, 2024Insider tradeSEC
4 · Change in ownershipFeb 6, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedFeb 6, 2024Big-stake noticeSEC
8-K · Current reportJan 25, 2024Current reportSEC
8-K · Current reportJan 19, 2024Material contractSEC
424B5 · ProspectusJan 19, 2024Offer documentSEC
8-K/A · Current report, amendedDec 5, 2023Management or board changeSEC
4 · Change in ownershipDec 5, 2023Insider tradeSEC
EFFECT · Notice that a registration is effectiveDec 1, 2023Other filingsSEC
8-K · Current reportNov 30, 2023Management or board changeSEC
CORRESP · Letter to the SECNov 28, 2023Other filingsSEC
UPLOAD · Letter from the SECNov 27, 2023Other filingsSEC
S-3 · Registration statementNov 22, 2023Offer documentSEC
4 · Change in ownershipNov 21, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedNov 20, 2023Big-stake noticeSEC
8-K · Current reportNov 20, 2023Current reportSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
4 · Change in ownershipNov 14, 2023Insider tradeSEC
10-Q · Quarterly reportNov 14, 2023Quarterly reportSEC
8-K · Current reportNov 14, 2023ResultsSEC
8-K · Current reportNov 13, 2023Management or board changeSEC
4 · Change in ownershipNov 8, 2023Insider tradeSEC
4 · Change in ownershipNov 3, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedNov 3, 2023Big-stake noticeSEC
SC 13D · Big-stake noticeNov 1, 2023Big-stake noticeSEC
4 · Change in ownershipNov 1, 2023Insider tradeSEC

This page holds 200 of 406 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from ProKidney Corp.’s releases · as of Sep 30, 2026

Common shares
208,926,941
Fully diluted
208,926,941

Fully diluted

LineSharesAs of
Common shares208,926,941Sep 30, 2026

Share count over time

CountShares
Nov 22, 2026208,926,941
Sep 30, 2026302,371,200

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Montanova Capital, LLC12.3M5.9%US$20.5MSep 30, 2026
Morgan Stanley9.85M4.7%US$16.4MSep 30, 2026
BlackRock7.97M3.8%US$13.2MSep 30, 2026
Geode Capital3.59M1.7%US$5.96MSep 30, 2026
Vanguard3.53M1.7%US$5.86MSep 30, 2026
Propel Bio Management, LLC2.01M0.96%US$3.34MSep 30, 2026
Bleichroeder LP1.9M0.91%US$3.15MSep 30, 2026
State Street1.81M0.87%US$3.01MSep 30, 2026
Hennion & Walsh Asset Management, Inc.1.81M0.86%US$3MSep 30, 2026
Schwab1.35M0.65%US$2.25MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Northern Trust1.01M0.48%US$1.68MSep 30, 2026
Millennium736K0.35%US$1.22MSep 30, 2026
MYDA Advisors LLC593K0.28%US$984KSep 30, 2026
Bank of America560K0.27%US$930KSep 30, 2026
Artia Global Partners LP554K0.27%US$919KSep 30, 2026
UBS537K0.26%US$891KSep 30, 2026
Simplify Asset Management Inc.484K0.23%US$803KSep 30, 2026
Two Sigma363K0.17%US$602KSep 30, 2026
Amundi304K0.15%US$505KSep 30, 2026
Gsa Capital Partners LLP295K0.14%US$490KSep 30, 2026
Cerity Partners LLC284K0.14%US$471KSep 30, 2026
Susquehanna226K0.11%US$375KSep 30, 2026
BNY220K0.11%US$366KSep 30, 2026
Voleon Capital Management LP210K0.10%US$349KSep 30, 2026
Virtus Investment Advisers, LLC193K0.09%US$321KSep 30, 2026
Carolina Financial Advisors, Inc183K0.09%US$303KSep 30, 2026
Goldman Sachs172K0.08%US$285KSep 30, 2026
Nuveen155K0.07%US$257KSep 30, 2026
DWS93,7110.04%US$156KSep 30, 2026
Barclays85,3320.04%US$142KSep 30, 2026
BNP Paribas80,5230.04%US$134KSep 30, 2026
AQR Capital Management LLC74,2460.04%US$123KSep 30, 2026
Quadrature Capital Ltd74,1860.04%US$123KSep 30, 2026
MetLife Investment Management, LLC67,1470.03%US$111KSep 30, 2026
T. Rowe Price62,0390.03%US$103KSep 30, 2026
Rhumbline Advisers56,0290.03%US$93,001Sep 30, 2026
Fidelity55,6870.03%US$92,441Sep 30, 2026
JPMorgan54,1080.03%US$88,196Sep 30, 2026
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.52,3070.03%US$86,830Sep 30, 2026
New York State Common Retirement Fund45,6000.02%US$75,696Sep 30, 2026
Wells Fargo45,5050.02%US$75,538Sep 30, 2026
Invesco45,5030.02%US$75,535Sep 30, 2026
Abel Hall, LLC39,7470.02%US$65,980Sep 30, 2026
Manufacturers Life Insurance Company, The34,6760.02%US$57,562Sep 30, 2026
Allspring Global Investments Holdings, LLC31,7920.02%US$53,093Sep 30, 2026
Aaron Wealth Advisors LLC29,6670.01%US$49,247Sep 30, 2026
Virtus Family Office LLC27,5000.01%US$45,650Sep 30, 2026
AllianceBernstein26,7600.01%US$44,422Sep 30, 2026
Police & Firemen's Retirement System of New Jersey25,3100.01%US$42,015Sep 30, 2026
Voya Investment Management LLC22,1530.01%US$36,774Sep 30, 2026

This page holds 50 of 88 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
iShares Russell 2000 ETF1.72M0.83%US$3.52MJun 30, 2026
Vanguard Extended Market Index Fund1.18M0.56%US$2.4MJun 30, 2026
Morgan Stanley Insight Fund1.12M0.54%US$2.28MJun 30, 2026
Morgan Stanley Discovery Portfolio1.08M0.52%US$2.21MJun 30, 2026
Fidelity Small Cap Index Fund822K0.39%US$1.27MJul 31, 2026
Discovery Portfolio821K0.39%US$1.67MJun 30, 2026
Fidelity Extended Market Index Fund534K0.26%US$978KMay 31, 2026
Schwab U.S. Small-Cap ETF505K0.24%US$924KMay 31, 2026
iShares Russell 2000 Growth ETF461K0.22%US$941KJun 30, 2026
Inception Portfolio292K0.14%US$597KJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
iShares Micro-Cap ETF254K0.12%US$517KJun 30, 2026
EQ/Morgan Stanley Small Cap Growth Portfolio213K0.10%US$434KJun 30, 2026
iShares Russell 2000 Value ETF208K0.10%US$424KJun 30, 2026
Fidelity Total Market Index Fund192K0.09%US$351KMay 31, 2026
Virtus Biotech Clinical Trials Etf190K0.09%US$292KJul 31, 2026
Schwab Small-Cap Index Fund186K0.09%US$286KJul 31, 2026
Discovery Portfolio171K0.08%US$349KJun 30, 2026
Fidelity Series Total Market Index Fund158K0.08%US$289KMay 31, 2026
Master Small Cap Index Series141K0.07%US$289KJun 30, 2026
Nuveen Small Cap Blend Index Fund101K0.05%US$156KJul 31, 2026
Fidelity Nasdaq Composite Index Fund86,9480.04%US$159KMay 31, 2026
EQ/2000 Managed Volatility Portfolio79,5040.04%US$162KJun 30, 2026
Schwab U.S. Broad Market ETF64,7640.03%US$119KMay 31, 2026
LVIP State Street Small-Cap Index Fund58,4000.03%US$119KJun 30, 2026
Global Insight Portfolio55,6980.03%US$114KJun 30, 2026
Fidelity ZERO Total Market Index Fund53,7690.03%US$82,804Jul 31, 2026
Fidelity Small Cap Growth Index Fund49,4360.02%US$101KJun 30, 2026
Schwab Total Stock Market Index Fund49,0000.02%US$75,460Jul 31, 2026
Fidelity ZERO Extended Market Index Fund37,1200.02%US$57,165Jul 31, 2026
Global X Russell 2000 ETF36,1580.02%US$55,683Jul 31, 2026
Small Cap Index Fund34,4790.02%US$70,337Jun 30, 2026
Fidelity Small Cap Value Index Fund32,4710.02%US$66,241Jun 30, 2026
State Street Small/Mid Cap Equity Index Portfolio28,3000.01%US$57,732Jun 30, 2026
ATM Small Cap Managed Volatility Portfolio25,4990.01%US$52,018Jun 30, 2026
iShares Russell Small/Mid-Cap Index Fund22,2510.01%US$34,267Jul 31, 2026
Small-Cap Index Portfolio21,0660.01%US$42,975Jun 30, 2026
Fidelity Flex Small Cap Index Fund17,415<0.01%US$26,819Jul 31, 2026
1290 VT Micro Cap Portfolio17,030<0.01%US$34,741Jun 30, 2026
Goldman Sachs Absolute Return Tracker Fund16,504<0.01%US$33,668Jun 30, 2026
NVIT Small Cap Index Fund16,341<0.01%US$33,336Jun 30, 2026
DWS Small Cap Index VIP11,819<0.01%US$24,111Jun 30, 2026
T. Rowe Price Small-Cap Index Fund11,407<0.01%US$23,270Jun 30, 2026
BlackRock Small Cap Index V.I. Fund10,031<0.01%US$20,463Jun 30, 2026
EQ/Small Company Index Portfolio8,920<0.01%US$18,197Jun 30, 2026
EQ/AB Small Cap Growth Portfolio8,920<0.01%US$18,197Jun 30, 2026
SA Small Cap Index Portfolio8,861<0.01%US$13,646Jul 31, 2026
VIP Extended Market Index Portfolio7,610<0.01%US$15,524Jun 30, 2026
CVT Russell 2000 Small Cap Index Portfolio6,867<0.01%US$14,009Jun 30, 2026
Nationwide Small Cap Index Fund6,592<0.01%US$10,152Jul 31, 2026
Victory Extended Market Index Fund6,538<0.01%US$10,069Jul 31, 2026

This page holds 50 of 73 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Pereira Brian JG
Director
Sale222,948USD 1.42US$317KAug 20, 2026
Pereira Brian JG
Director
Sale27,052USD 1.42US$38,414Aug 20, 2026
Pereira Brian JG
Director
Sale222,949USD 1.44US$321KAug 19, 2026
Pereira Brian JG
Director
Sale27,051USD 1.44US$38,953Aug 19, 2026
Pereira Brian JG
Director
Sale229,338USD 1.37US$314KAug 18, 2026
Pereira Brian JG
Director
Sale27,826USD 1.37US$38,122Aug 18, 2026

Big stakes

StakeStakeSharesDateFiling
Control Empresarial de Capitales S.A. de C.V.36.00%73.8MApr 28, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chamath Palihapitiya
Other companies: Colombier Acquisition Corp. III (Director · Since at least Feb 3, 2026); American Exceptionalism Acquisition Corp. A (Director · Since at least Sep 25, 2025); Akili Inc (Director · Jul 2, 2021 – May 2, 2023 · Past); Social Capital Suvretta Holdings Corp II (President, Director · Jul 2, 2021 – Aug 16, 2021 · Past); Social Capital Suvretta Holdings Corp IV (President, Director · Jul 2, 2021 – Aug 16, 2021 · Past); Social Capital Hedosophia Holdings Corp IV (CEO & Chairman of the Board, Director · Oct 8, 2020 – Oct 8, 2020 · Past); Social Capital Hedosophia Holdings Corp VI (CEO & Chairman of the Board, Director · Oct 8, 2020 – Oct 8, 2020 · Past); SoFi Technologies, Inc. (CEO & Chairman of the Board, Director · Oct 8, 2020 – Oct 8, 2020 · Past); Opendoor Technologies Inc (CEO & Chairman of the Board, Director · Apr 27, 2020 – Apr 27, 2020 · Past); Clover Health Investments, Corp. (CEO & Chairman of the Board, Director · Apr 21, 2020 – Apr 21, 2020 · Past); Slack Technologies Inc (Director · Jun 7, 2019 – Dec 10, 2019 · Past); Virgin Galactic Holdings, Inc. (Director · Sep 13, 2017 – Mar 18, 2021 · Past)
President, Director · Jul 2, 2021 – Aug 16, 2021 · Past
John M. Maraganore
Other companies: City Therapeutics, Inc. (Executive Chair · Since at least Oct 19, 2026); Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Jan 29, 2026); Rapport Therapeutics, Inc. (Venture Partner, ARCH Venture Partners and Atlas Ventures · Since at least Jun 6, 2024); Kymera Therapeutics, Inc. (Director · Since at least Jan 17, 2022); Beam Therapeutics Inc. (Board Member · Since at least Nov 5, 2021); Alnylam Pharmaceuticals, Inc. (Director · Since at least May 12, 2006); Instil Bio, Inc. (Director · Jun 11, 2025 – Nov 4, 2026 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Dec 31, 2022 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Sep 14, 2017 · Past); Regulus Therapeutics Inc (Director · Oct 4, 2012 – Oct 10, 2012 · Past)
Director · Jul 11, 2022 – Jun 29, 2023 · Past
James Ryans
Other companies: Akili Inc (Chief Financial Officer · Jun 29, 2021 – Jun 29, 2021 · Past); Social Capital Suvretta Holdings Corp II (Chief Financial Officer · Jun 29, 2021 – Jun 29, 2021 · Past); Social Capital Suvretta Holdings Corp IV (Chief Financial Officer · Jun 29, 2021 – Jun 29, 2021 · Past); Social Capital Hedosophia Holdings Corp IV (Chief Financial Officer · May 31, 2021 – May 31, 2021 · Past); Social Capital Hedosophia Holdings Corp VI (Chief Financial Officer · May 31, 2021 – May 31, 2021 · Past); Clover Health Investments, Corp. (Director · Apr 21, 2020 – Apr 21, 2020 · Past); Virgin Galactic Holdings, Inc. (Director · Feb 5, 2018 – Dec 16, 2020 · Past)
Chief Financial Officer · Jun 29, 2021 – Jun 29, 2021 · Past
Jennifer Fox
Other companies: Zenas BioPharma, Inc. (See Remarks · Since at least Sep 12, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Nuvation Bio Inc. (Chief Financial Officer · Feb 10, 2021 – Feb 28, 2023 · Past)
Director · Since at least Jul 11, 2022
Marc Semigran
Other companies: Edgewise Therapeutics, Inc. (Chief Development Officer · Dec 19, 2022 – Dec 24, 2024 · Past); MyoKardia Inc (Chief Medical Officer · Dec 1, 2016 – Feb 8, 2019 · Past)
Director · Jun 29, 2021 – Jun 29, 2021 · Past
Mary Weger
Other companies: Medidata Solutions Inc (EVP, Human Resources · Feb 23, 2017 – Feb 24, 2017 · Past); Aegerion Pharmaceuticals Inc (Chief Performance Officer · Mar 29, 2015 – Aug 4, 2015 · Past)
Chief People Officer · Dec 1, 2022 – Jan 16, 2023 · Past
Timothy Bertram
Other companies: NexImmune, Inc. (Director · Feb 11, 2021 – Jul 5, 2023 · Past); Tengion Inc (Pres Rsrch & Dev, & Chf Sc Ofc · Apr 9, 2010 – Mar 4, 2013 · Past)
Chief Executive Officer, Director · Jul 11, 2022 – Jan 16, 2023 · Past
Todd C. Girolamo
Other companies: Longeveron Inc. (Director · Feb 15, 2022 – Dec 21, 2022 · Past); Lisata Therapeutics, Inc. (CLO, SVP of Corp Dev · Jun 17, 2021 – Jan 13, 2022 · Past)
Chief Legal Officer and Secretary · Since at least Jul 11, 2022
Brian J. G. Pereira
Other companies: KalVista Pharmaceuticals, Inc. (Director · Since at least Oct 3, 2024)
Director · Since at least May 30, 2024
William Doyle
Other companies: NovoCure Limited (Executive Chairman · Since at least Dec 22, 2025)
Lead Independent Director · Since at least Nov 19, 2026
All 28 people
PersonSeat
Alan M. LotvinBoard Member · Since at least Nov 19, 2026
Bruce CulletonChief Executive Officer, Director · Since at least Mar 1, 2026
Carla PoulsonChief People Officer · Since at least Nov 19, 2026
Darin J. WeberChief Regulatory Officer · Since at least Jul 11, 2022
Deepak JainChief Operating Officer · Jul 11, 2022 – Jan 16, 2023 · Past
Emily ButlerSVP, Biometrics · Since at least Nov 5, 2026
Farah AliChief Medical Officer · Since at least Nov 18, 2026
Greg MadisonChief Commercial Officer · Since at least Mar 25, 2026
Jake TreeseSVP, Head of Quality · Since at least Nov 19, 2026
James CoulstonChief Financial Officer · Since at least Mar 1, 2026
Joseph StavasSVP, Interventional Procedures · Since at least Nov 19, 2026
Ken LockeChief Technical Officer · Since at least Aug 10, 2026
Libbie Parker McKenzieChief Medical Officer · Jul 11, 2022 – Jan 16, 2023 · Past
Pablo LegorretaChairman of the Board · Since at least Nov 19, 2026
Richard WilliamsChief Information Officer · Since at least Nov 19, 2026
Santos Jose Ignacio JimenezDirector · Since at least Jul 11, 2022
Ulrich Peter Alfred ErnstEVP, Technical Operations · Mar 25, 2024 – Apr 1, 2024 · Past
Uma SinhaDirector · Since at least May 29, 2025

Open People

Log in to ask 6ix AI your own questions about ProKidney Corp.